Zusammenfassung
Fette und Lipoide nehmen bezüglich der Körpermasse nach Wasser und Eiweiß die dritte Position ein.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Assmann G (1982) Lipidstoffwechsel und Atherosklerose. FK Schattauer, Stuttgart
Beil U, Grundy SM, Crouse JR, Zech L (1982) Triglyceride and cholesterol metabolism in primary hypertriglyceridemia. Arteriosclerosis 2: 44
Borne, P (1969) Type 3 hyperlipoproteinaemia. Br Med J 2: 665
Brunzell JD, Albers JJ, Chait A, Grundy SM, Groszek E, McDonald GB (1983) Plasma lipoproteins in familial combined hyperlipid-emia and monogenic familial hypertriglyceridemia. J Lipid Res 24: 147
Carlson LA, Bottiger LE (1972) Ischaemic heart-disease in relation to fasting values of plasma triglycerids and cholesterol. Stockholm prospective study. Lancet 1: 865
Carlson LA, Bottiger LE, Ahlfeldt PE (1979) Risk factors for myocardial infarction on Stockholm prospective study. A 14-year follow-up fo-cusing on the role of plasma triglycerides and cholesterol. Acta Med Scand 206: 351
Chait A, Albers JJ, Brunzell JD (1980) Very low density lipoprotein overproduction in genetic forms of hypertriglyceridemia. Eur J Clin Invest 10: 161
Fredrickson, Donald S, Lees RS (1965) A System for phenotyping hyperlipoproteinemia. Circulation 31
Eggstein M, Kreutz FH (1966) Eine neue Bestimmung der Neutralfette im Blutserum und Gewebe. I. Mitteilung: Prinzip, Durchführung und Besprechung der Methode. Klin Wschr 44: 262–267
Eggstein M (1966a) Eine neue Bestimmung der Neutralfette im Blutserum und Gewebe. II. Mitteilung: Zuverlässigkeit der Methode, andere Neutralfettbestimmungen, Normalwerte für Triglyceride und Glycerin im menschlichen Blut. Klin Wschr 44: 267–273
Eggstein M (1966b) Carbohydrates and lipid metabolism. In: „Pathophysiologische und klinische Aspekte des Fettstoffwechsels“. Editors Schettler G, Sanwald R, Georg Thieme, Stuttgart, 65–71
Fisher WR (1983) Heterogeniety of plasma low density lipoproteins manifestations of the physiologic phenomenon in man. Metabolism 32: 283
Gianturco SH, Gotto AM (1978) Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia. J Clin Invest 61: 320
Gianturco SH, Eskin SG, Navarro LT, Lahart CJ et al. (1980) Abnormal effects of hypertriacylglycerolemie very low density lipoproteins on 3-hydroxy-3-methylglutaryl-CoA reductase activity and viability of cultured bovine aortic endothelial cells. Biochim Biophys Acta 618: 143
Goldstein JL, Hazzard WR, Schrott HG, Biermann EL, Motulsky AG (1973a) Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest 52: 1533
Goldstein JL, Schrott HG, Hazzard WR, Biermann EL, Motulsky AG (1973b) Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 52: 1544
Gotto AM, Phil D, Gorry A, Thompson JR, Cole JS, Trost R, Yeshurun D, Debakey ME (1977) Relationship between plasma lipid concentrations and coronary artery disease in 496 patients. Circulation 56: 875
Hessel LW, Vermeer BJ, Polano MK, Dejonge H, Depagter HAT (1976) Primary hyperlipo-protein-emia in xanthomatosis. Clin Chim Acta 69: 405
Hulley SB, Rosenmann RH, Bawol RD, Brand RJ (1980) Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary disease. N Engl J Med 302: 1383
Janus ED, Nicoll AM, Turner PR, Magill P, Lewis B (1980) Kinetic bases of the primary hyperlipidemias: studies of apolipoprotein B turnover in genetically defined subjects. Eur J Clin Invest 10: 161
John W, Gofman MD, Hardin B et al. (1950) Blood lipids an human atherosclerosis. Circulation 2
Kane JB, Malloy MJ (1983) Disorders of Lipoprotein Metabolism. In: “Basic and clinical Endocrinology”. Greenspan FS, Forsham PH. Lange
Kissebah AH, Alfarsi S, Adams PW (1981) Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial combined hyperlipidemia. Metabolism 30: 856
Kunkel, Slater R (1952) Lipoprotein patters of serum obtained by zone electrophoresis. J clin Invest (Am) 31: 677
Mahley RW (1982) Atherogenic hyperlipoproteinemia. The cellular and molecular biology of plasma lipoproteins altered by dietary fat and cholesterol. Med Clin North Am 66: 375
Mahley RW, Innerarity TL (1983) Lipoproteinreceptors and cholesterol homeostasis. Biochim Biophys Acta 737: 197
Schaefer EJ, Levy RJ (1985) Pathogenesis and Management of Lipoprotein Disorders. New Engl J Med 312:1300–1310
Schettler G, Eggstein M, Dietrich F (1956) Zur papierelektrophoretischen Bestimmung der Lipoproteide. Klin Wschr 34: 684–688
Stamler J (1979) Public health aspects of optimal serum lipid-lipoprotein levels. Prev Med 8:733
Vega GL, Illingworth DR, Grundy SM, Lindgren FT, Connor WE (1983) Normocholesterolemic tendon xanthomatosis with overproduction of apolipoprotein B. Metabolism 32: 118
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Eggstein, M. (1988). Triglyzeridforschung. In: Mörl, H., Diehm, C., Heusel, G. (eds) 45 Jahre Herzinfarkt- und Fettstoffwechselforschung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73440-3_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-73440-3_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-18945-9
Online ISBN: 978-3-642-73440-3
eBook Packages: Springer Book Archive